Description

Etoricoxib is a potent and selective COX?2 inhibitor that reduces prostaglandin production, making it valuable for studies of inflammation, pain, and arthritis. It shows high oral bioavailability and strong enzyme selectivity. The Zhenbaodao formulation provides a consistent 60?mg dose per tablet, intended for preclinical and pharmacological research involving inflammatory pathways and biochemical assays.

Manufactured under strict quality controls by Harbin Zhenbao Pharmaceutical Co., Ltd., and approved under China NMPA registration number H20234178, national drug code 86903783000567, barcode 6946617600834.

?? This product is strictly for laboratory research use and not approved for clinical, therapeutic, or veterinary use.

Etoricoxib Tablets Product Specifications

Etoricoxib Tablets Mechanism & Research Applications

Etoricoxib selectively inhibits the COX?2 enzyme, which prevents prostaglandin synthesis from arachidonic acid . With approximately 100-fold selectivity over COX?1, it reduces inflammation and pain while minimizing gastric side effects.

This makes it ideal for research purposes such as:

• Inflammation and pain model development

• Prostaglandin pathway analysis

• Comparative pharmacology of NSAIDs

• Enzyme activity and selectivity studies

• Preclinical evaluation of new anti-inflammatory agents

Etoricoxib Tablets Side Effects (Observed in Research Models)

In animal and cell-based research, administration of etoricoxib may demonstrate:

• Minor gastric irritation

• Fluid retention or edema

• Altered blood pressure in prolonged dosing

• Possible cardiovascular biomarker changes

• Rare skin sensitivity at higher doses

Use appropriate monitoring and laboratory controls when used in vivo.

Safety & Handling

• Research Use Only: Not for human or veterinary use

• Handling: Wear gloves, safety goggles, and lab coat

• Storage: Keep sealed in a cool, dry area below 30?°C

• Disposal: Dispose according to institutional chemical safety protocols

Core Keywords

Etoricoxib tablets, Zhenbaodao etoricoxib, COX?2 inhibitor for lab, inflammation research reagent, pain model compound, lab?grade NSAID, selective COX?2 tablet, NMPA H20234178 etoricoxib, Harbin Zhenbao lab tablets, wholesale etoricoxib tablets

Research Use Disclaimer

This product is exclusively for laboratory research purposes. It is not designed or approved for therapeutic, diagnostic, clinical, or veterinary use. Misuse can pose significant safety or regulatory risks. Always comply with institutional biosafety protocols.